The Gerontologist · 2026
Implementing a conversation-starter tool to empower people with dementia and carers to have medicine conversations: a pilot and feasibility study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ailabouni Nagham J, Reeve Emily, Hanjani Leila S, Theodos Alex, Olsen Will, Bohill Ruth, Brandt Nicole, Freeman Christopher R, Hubbard Ruth E, Mangin Dee, Weir Kristie R
Аннотация
BACKGROUND AND OBJECTIVES: The PRIME (PReparing people living with dementia and carers to Initiate conversations about MEdicines) tool empowers consumers (people living with dementia or mild cognitive impairment and their carers) to start conversations about their medicines with their clinicians. This study aimed to test the implementation (feasibility, acceptability, and adoption) of the PRIME tool amongst people with memory problems and their carers (consumers) attending a geriatric medicine clinic.
RESEARCH DESIGN AND METHODS: This is a before and after (pre-post) interventional Hybrid Type 3 pilot and feasibility study using a mixed-methods approach. Consumers and clinicians were recruited. The study pharmacist conducted a medicine reconciliation for consumers at baseline (T0) and gave them the PRIME tool to use before their medical appointment. Data were collected at baseline (T0), post-medical appointment (T1), and 3 months after the appointment (T2). One-on-one interviews with consumer and clinician participants were conducted at T1.
RESULTS: Twenty-three consumers and 7 clinicians (geriatricians or advanced geriatric medicine trainees) were recruited. It was feasible to implement the PRIME tool. Most consumers used the tool during or prior to their medical appointment and had a conversation about their medicines with their clinician (92.3%; primary outcome).
DISCUSSION AND IMPLICATIONS: The PRIME tool was adopted by participants and considered to be acceptable. Our findings suggest that the tool may encourage more conversations about medicines to occur in practice. Empowering consumers to engage in conversations with their clinician about their medicines may lead to improved use of medicines and health outcomes.
RESEARCH DESIGN AND METHODS: This is a before and after (pre-post) interventional Hybrid Type 3 pilot and feasibility study using a mixed-methods approach. Consumers and clinicians were recruited. The study pharmacist conducted a medicine reconciliation for consumers at baseline (T0) and gave them the PRIME tool to use before their medical appointment. Data were collected at baseline (T0), post-medical appointment (T1), and 3 months after the appointment (T2). One-on-one interviews with consumer and clinician participants were conducted at T1.
RESULTS: Twenty-three consumers and 7 clinicians (geriatricians or advanced geriatric medicine trainees) were recruited. It was feasible to implement the PRIME tool. Most consumers used the tool during or prior to their medical appointment and had a conversation about their medicines with their clinician (92.3%; primary outcome).
DISCUSSION AND IMPLICATIONS: The PRIME tool was adopted by participants and considered to be acceptable. Our findings suggest that the tool may encourage more conversations about medicines to occur in practice. Empowering consumers to engage in conversations with their clinician about their medicines may lead to improved use of medicines and health outcomes.